Kleodina

Ethinylestradiol and Levonorgestrel, the active ingredients in Kleodina, are a combined oral contraceptive presented as a tablet for oral use. The formulation works by preventing ovulation and creating conditions unfavorable for fertilisation, providing reliable pregnancy prevention for women of reproductive age.

GNH USA supplies Kleodina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across global markets. The product conforms to European Union pharmaceutical standards and is manufactured under GMP conditions.

Kleodina, a combined oral contraceptive, is used within the hormonal contraception pathway to prevent pregnancy. - Pregnancy prevention: Provides reliable contraception for women of reproductive age. - Menstrual cycle regulation: Helps achieve more regular and predictable menstrual bleeding. - Treatment of acne related to androgen excess: Reduces skin lesions by modulating hormonal levels.

Kleodina may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects: - Nausea: Mild to moderate stomach upset. - Breast tenderness: Temporary discomfort or swelling. - Headache: Occasional mild to moderate pain. - Spotting or breakthrough bleeding: Irregular light bleeding. - Mood changes: Fluctuations in emotional state. - Weight gain: Slight increase in body weight.

Serious or Rare Side Effects: - Deep vein thrombosis: Blood clot formation in deep veins. - Pulmonary embolism: Clot migration to lung vessels. - Stroke: Disruption of cerebral blood flow. - Myocardial infarction: Heart attack due to blocked coronary arteries. - Severe allergic reaction: Anaphylaxis with rash, swelling, or breathing difficulty. - Liver tumor: Benign hepatic adenoma in rare cases.

Before prescribing Kleodina, clinicians should consider several safety aspects. - Cardiovascular risk assessment: Evaluate history of thromboembolic events. - Smoking status: Advise against use in women over 35 who smoke. - Liver function: Check for hepatic impairment before initiation. - Pregnancy and lactation: Avoid use during pregnancy; discuss breastfeeding considerations. - Drug interaction review: Assess concomitant medications that may affect efficacy. - Store at ambient temperature: Keep tablets in the original container, protect from moisture and direct sunlight.

Kleodina can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine): May markedly reduce contraceptive efficacy. - Anticoagulants (e.g., warfarin): May increase INR and bleeding risk. - Certain antiretrovirals (e.g., efavirenz): Can lower hormone levels.

Moderate Interactions (Monitor Closely): - Antibiotics such as tetracycline: May slightly decrease absorption. - Herbal supplements (e.g., St. John's wort): Potential reduction in effectiveness. - Antihypertensives: May cause modest blood pressure elevation.